loading

Finanzdaten der Arrowhead Pharmaceuticals Inc-Aktie (ARWR)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
100.00%
-
3.551 16.10 15.82 146.27
Operating Expenses
9.93%
126.19
140.10 124.43 118.53 98.10
Interest Income/Expense
34.97%
7.244
5.367 5.262 5.158 5.057
Benefits Costs and Expenses
10.72%
127.00
142.24 125.09 119.21 98.59
Costs And Expenses
10.72%
127.00
142.24 125.09 119.21 98.59
Depreciation and Amortization
6.15%
4.525
4.263 3.859 3.276 2.669
Operating Income/Loss
7.58%
-126.19
-136.54 -108.33 -102.70 48.16
Nonoperating Income/Loss
62.45%
-0.805
-2.144 -0.66 -0.68 -0.489
Income/Loss From Continuing Operations Before Tax
8.43%
-127.00
-138.69 -108.99 -103.38 47.68
Income Tax Expense/Benefit
100.00%
-
-3.313 2.025 0.742 -
Income/Loss From Continuing Operations After Tax
6.19%
-127.00
-135.38 -111.02 -104.12 48.67
Net Income/Loss
6.19%
-127.00
-135.38 -111.02 -104.12 47.68
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
32.48%
-1.696
-2.512 -1.336 -1.179 -0.999
Basic Average Shares
14.77%
123.28
107.42 0.153 107.00 106.76
Diluted Average Shares
14.77%
123.28
107.42 0.153 107.00 108.14
Basic Earnings Per Share
17.74%
-1.02
-1.24 -1.02 -0.96 0.46
Diluted Earnings Per Share
17.74%
-1.02
-1.24 -1.02 -0.96 0.45
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Kapitalisierung:     |  Volumen (24h):